Engineering attenuated virus vaccines by controlling replication fidelity.

Engineering attenuated virus vaccines by controlling replication fidelity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Engineering attenuated virus vaccines by controlling replication fidelity. Abstract Text:

Marco Vignuzzi,Emily Wendt,Raul Andino,

Long-lasting protection against viral infection is best achieved by vaccination with attenuated viruses. Obtaining stably attenuated vaccine strains has traditionally been an empirical process, which greatly restricts the number of effective vaccines for viral diseases. Here we describe a rational approach for engineering stably attenuated viruses that can serve as safe and effective vaccines. Our approach exploits the observation that restricting viral population diversity by increasing replication fidelity greatly reduces viral tissue tropism and pathogenicity. We show that poliovirus variants with reduced genetic diversity elicit a protective immune response in an animal model of infection. Indeed, these novel vaccine candidates are comparable in efficacy to the currently available Sabin type 1 vaccine strain, but have the added advantage of being more stable, as their increased replication fidelity prevents reversion to the pathogenic wild-type phenotype. We propose that restricting viral quasispecies diversity provides a general approach for the rational design of stable, attenuated vaccines for a wide variety of viruses.

Engineering attenuated virus vaccines by controlling replication fidelity. Publishing Authors By Initials

M Vignuzzi,E Wendt,R Andino,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Engineering attenuated virus vaccines by controlling replication fidelity. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Nature medicine

VOLUME: 14

Page Numbers: 154-61

Journal Abbreviation: Nat. Med.

ISSN: 1546-170X

DAY: 3

MONTH: 02

YEAR: 2008

Engineering attenuated virus vaccines by controlling replication fidelity. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9502015

Engineering attenuated virus vaccines by controlling replication fidelity. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Engineering attenuated virus vaccines by controlling replication fidelity. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Engineering attenuated virus vaccines by controlling replication fidelity.

AFFILIATION: Department of Microbiology and Immunology, University of California-San Francisco, 600 16th Street, San Francisco, California 94143-2280, USA.

Country: United States

AGENCY: United States NIAID

GRANT: AI40085

ACRONYM: AI

MEDLINETA: Nat Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Engineering attenuated virus vaccines by controlling replication fidelity Related Publications

• A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.
• Engineering attenuated virus vaccines by controlling replication fidelity.
• Harnessing Endogenous miRNAs to Control Virus Tissue Tropism as a Strategy for Developing Attenuated Virus Vaccines.
• Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex.
• The RNA silencing endonuclease Argonaute 2 mediates specific antiviral immunity in Drosophila melanogaster.
• The silent treatment: RNAi as a defense against virus infection in mammals.